再生元制药 REGN 深 沪
等待开盘 10-06 09:30:00 美东时间
726.94
-8.260
-1.12%
华盛通- 最 高859.34
- 今 开735.40
- 成交量 63.56万股
- 最 低 722.02
- 昨 收 735.20
- 总市值 7996.34万
- 52周最高 859.34
- 市盈率 静 10.10
- 换手率 577.78%
- 52周最低 537.30
- 委 比 82.56%
- 总股本 0.00亿
- 历史最高 1204.8599
- 量 比 0.67
- 振 幅 18.68%
- 历史最低 -5.24
- 每 手 1
- 风险率 73.08%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Regeneron Highlights Promising Ovarian Cancer, Muscle Preservation Trial Data
Regeneron reports positive trial data for ubamatamab in ovarian cancer and trevogrumab for muscle preservation during weight loss.
10-03 01:19
Kodiak Sciences Says Eye Drug on Par with Regeneron's Medicine
Kodiak Sciences announced positive data from its Phase 3 DAYBREAK study for its eye treatments Zenkuda and tabirafusp-ted.
09-28 22:05
Mirum Pharmaceuticals and Incyte Compete Regeneron with Abnormal Bone Formation Treatment
The FDA approved Atebrioz by Mirum Pharmaceuticals and Incyte to treat FOP in patients aged 12 and older, reducing abnormal bone formation.
09-28 20:38
FDA Approves Telix Pharmaceuticals Brain Cancer Imaging Drug
FDA approves Telix Pharmaceuticals' Pixclara, the first radiopharmaceutical brain cancer imaging drug for glioma PET scans.
09-14 21:50
Sanofi Drops Dupixent Successor Candidate After Assessing Data
Sanofi discontinued amlitelimab for atopic dermatitis after reviewing phase 3 efficacy and safety data, ending plans for regulatory filings.
07-25 02:10
Ocular Therapeutix Maps Regulatory Strategy For Lead Drug Program
Ocular outlines FDA-aligned AXPAXLI NDA plan for wet AMD by Q4 2026, revises SOL-R study design, and streamlines DR program.
06-17 22:55
Critical Metals Stock Drops Despite European Lithium Deal
Critical Metals (NASDAQ: CRML) shares are dropping Monday after it signed a binding Scheme Implementation Deed to acquire European Lithium.
05-19 01:54
ReNew Reports Q4 Double Beat, Record Full-Year Net Profit
ReNew Energy Global Plc (NASDAQ: RNW) reported fourth-quarter earnings Monday before the market opened. Here's a rundown of the report.
05-18 23:01
Lakewood-Amedex Stock Falls Despite Positive Nu-3 Manufacturing Update
Lakewood-Amedex Biotherapeutics shares were trading higher Monday but have reversed lower after the company announced data for Nu-3.
05-18 22:11
Nokia Shares Edge Higher Following Patent Victory, Management Revamp
Nokia (NYSE: NOK) shares are edging higher in Monday's pre-market as traders weigh UK patent fallout, leadership shifts, and firmer Nasdaq.
05-18 21:03
